Genetic studies of diseases: Predicting siRNA efficiency

Cellular and Molecular Life Sciences

Volumn 64, Issue 14, 2007, Pages 1785-1792

  Li, W ^a   Cha, L ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Algorithm; Prediction; RNAi; siRNA

Indexed keywords

SMALL INTERFERING RNA; MESSENGER RNA;

ANTIVIRAL ACTIVITY; CANCER; COMPUTER PROGRAM; DNA STRUCTURE; DRUG EFFECT; GENE EXPRESSION; GENE INTERACTION; GENE MAPPING; GENETIC DISORDER; HUMAN; LIVER DISEASE; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; REVIEW; RNA INTERFERENCE; RNA SEQUENCE; VIRUS GENE; VIRUS INFECTION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CONFORMATION; GENE TARGETING; SEQUENCE ANALYSIS;

ANIMALS; GENE TARGETING; MODELS, GENETIC; NUCLEIC ACID CONFORMATION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; SOFTWARE;

EID: 34447626821     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7057-3     Document Type: Review

References (83)

1. Robinson, R. (2004) RNAi therapeutics: how likely, how soon? PLoS Biol. 2, E28.
2. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S. E. and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 8061-811.
3. Keating C.D., Kriek N., Daniels M., Ashcroft N. R., Hopper N. A., Siney E. J., Holden-Dye L. and Burke J. F. (2003) Whole-genome analysis of 60 G protein-coupled receptors in Caenorhabditis elegans by gene knockout with RNAi. Curr. Biol. 13, 1715-1720.
4. Barstead R. (2001) Genome-wide RNAi. Curr. Opin. Chem. Biol. 5, 63-66.
5. Agaisse H., Burrack L. S., Philips J. A., Rubin E. J., Perrimon N. and Higgins D. E. (2005) Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science 309, 1248-1251.
6. Simmer F., Moorman C., van der Linden A. M., Kuijk E., van den Berghe P. V., Kamath R. S., Fraser A. G., Ahringer J. and Plasterk R. H. (2003) Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1, E12.
7. Sugimoto A. (2004) High-throughput RNAi in Caenorhabditis elegans: genome-wide screens and functional genomics. Differentiation 72, 81-91.
8. Kuttenkeuler D. and Boutros M. (2004) Genome-wide RNAi as a route to gene function in Drosophila. Brief Funct. Genomic. Proteomic. 3, 168-176.
9. Moffat J. and Sabatini D. M. (2006) Building mammalian signalling pathways with RNAi screens. Nat. Rev. Mol. Cell Biol. 7, 177-187.
10. Furlong E. E. (2005) A functional genomics approach to identify new regulators of Wnt signaling. Dev. Cell 8, 624-626.
11. Jana S., Chakraborty C., Nandi S. and Deb J. K. (2004) RNA interference: potential therapeutic targets. Appl. Microbiol. Biotechnol. 65, 649-657.
12. Tan F. L. and Yin J.Q. (2004) RNAi, a new therapeutic strategy against viral infection. Cell Res. 14, 460-466.
13. Silva J. M., Hammond, S. M. and Hannon G. J. (2002) RNA interference: a promising approach to antiviral therapy? Trends Mol. Med. 8, 505-508.
14. Bennink J. R. and Palmore T.N. (2004) The promise of siRNAs for the treatment of influenza. Trends Mol. Med. 10, 571-574.
15. McCaffrey A. P., Nakai H., Pandey K., Huang Z., Salazar F. H., Xu H., Wieland S. F., Marion P. L. and Kay M. A. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21, 639-644.
16. Radhakrishnan S. K., Layden T. J. and Gartel A. L. (2004) RNA interference as a new strategy against viral hepatitis. Virology 323, 173-181.
17. Hu W. Y., Bushman F. D. and Siva A. C. (2004) RNA interference against retroviruses. Virus Res. 102, 59-64.
18. Lee N. S. and Rossi J. J. (2004) Control of HIV-1 replication by RNA interference. Virus Res. 102, 53-58.
19. Li X. P., Li G., Peng Y., Kung H. F. and Lin M. C. (2004) Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem. Biophys.Res. Commun. 315, 212-218.
20. Cristofaro P. and Ramratnam B. (2006) RNAi tackles a sexually transmitted disease. Nat. Biotechnol. 24, 48-49.
21. Sim A. C., Luhur A., Tan T. M., Chow V. T. and Poh C. L. (2005) RNA interference against enterovirus 71 infection. Virology 341, 72-79.
22. Stevenson M. (2003) Dissecting HIV-1 through RNA interference. Nat. Rev. Immunol. 3, 851-858.
23. Jacque J. M., Triques K. and Stevenson M. (2002) Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438.
24. De Francesco R. and Migliaccio G. (2005) Challenges and successes in developing new therapies for hepatitis C. Nature 436, 953-960.
25. Bitko V., Musiyenko A., Shulyayeva O. and Barik S. (2005) Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50-55.
26. Zhang Y., Li T., Fu L. Yu C., Li Y., Xu X., Wang Y., Ning H., Zhang S., Chen W. et al. (2004) Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett. 560, 141-146.
27. Li Y., Wasser S., Lim S. G. and Tan T.M. (2004) Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication. Cell. Mol. Life Sci. 61, 2113-2124.
28. Palliser D., Chowdhury D., Wang Q. Y., Lee S. J., Bronson R. T., Knipe D. M. and Lieberman J. (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89-94.
29. Ito M., Kawano K., Miyagishi M. and Taira K. (2005) Genome-wide application of RNAi to the discovery of potential drug targets. FEBS Lett. 579, 5988-5995.
30. Hauber I., Bevec D., Heukeshoven J., Kratzer F., Horn F., Choidas A., Harrer T. and Hauber J. (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J. Clin. Invest. 115, 76-85.
31. Jones S. W., Souza P. M. and Lindsay M. A. (2004) siRNA for gene silencing: a route to drug target discovery. Curr. Opin. Pharmacol. 4, 522-527.
32. Lavery K. S. and King T. H. (2003) Antisense and RNAi: powerful tools in drug target discovery and validation. Curr. Opin. Drug Discov. Devel. 6, 561-569.
33. Cherry S., Doukas T., Armknecht S., Whelan S., Wang H., Sarnow P. and Perrimon N. (2005) Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 19, 445-452.
34. Ait-Si-Ali S., Guasconi V. and Harel-Bellan A. (2004) RNA interference and its possible use in cancer therapy. Bull. Cancer 91, 15-18.
35. Devi G. R. (2006) siRNA-based approaches in cancer therapy. Cancer Gene Ther. Cancer Gene Ther. 13, doi: 10.1038/sj.cgt.7700931
36. Sciamanna I., Landriscina M., Pittoggi C., Quirino M., Mearelli C., Beraldi R., Mattei E., Serafino A., Cassano A., Sinibaldi-Vallebona P. et al. (2005) Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 24, 3923-3931.
37. Pai S. I., Lin Y. Y., Macaes B., Meneshian A., Hung C. F. and Wu T. C. (2006) Prospects of RNA interference therapy for cancer. Gene Ther. 13, 464-477.
38. Bhattacharyya M. and Lemoine N. R. (2006) Gene therapy developments for pancreatic cancer. Best. Pract. Res. Clin. Gastroenterol. 20, 285-298.
39. Harper S. Q., Staber P. D., He X., Eliason S. L., Martins I. H., Mao Q., Yang L., Kotin R. M., Paulson H. L. and Davidson B. L. (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820-5825.
40. Caplen N. J., Taylor J. P., Statham V. S., Tanaka F., Fire A. and Morgan R. A. (2002) Rescure of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet. 11, 175-184.
41. Pomerantz R. J. (2002) RNA interference meets HIV-1: will silence be golden? Nat. Med. 8, 659-660.
42. Song E., Lee S., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P. and Lieberman J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347-351.
43. Li B., Tang Q., Cheng D., Qin C., Xie F. Y., Wei Q., Xu J., Liu Y., Zheng B. J., Woodle M. C. et al. (2005) Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11, 944-951.
44. Dykxhoorn D. M., Palliser D. and Lieberman J. (2006) The silent treatment: siRNAs as small molecule drugs. Gene Ther. 13, 541-552.
45. Tan F. L. and Yin J. Q. (2005) Application of RNAi to cancer research and therapy. Front. Biosci. 10, 1946-1960.
46. Bussey H., Andrews B. and Boone C. (2006) From worm genetic networks to complex human diseases. Nat. Genet. 38, 862-863.
47. Lehner B., Crombie C., Tischler J., Fortunato A. and Fraser A. G. (2006) Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 38, 896-903.
48. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W. S. and Khvorova A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330.
49. Jagla B., Aulner N., Kelly P. D., Song D., Volchuk A., Zatorski A., Shum D., Mayer T., De Angelis D. A., Ouerfelli O. et al. (2005) Sequence characteristics of functional siRNAs. RNA 11, 864-872.
50. Patzel V., Rutz S., Dietrich I., Koberle C., Scheffold A. and Kaufmann S. H. (2005) Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat. Biotechnol. 23, 1440-1444.
51. Huesken D., Lange J., Mickanin C., Weiler J., Asselbergs F., Warner J., Meloon B., Engel S., Rosenberg A., Cohen D. et al. (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23, 995-1001.
52. Elbashir S. M., Harborth J., Weber K. and Tuschl T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213.
53. Luo K.Q. and Chang D.C. (2004) The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem. Biophys. Res. Commun. 318, 303-310.
54. Gerrit S. and Rebecca R. (2005) siRNA design including secondary structure target site prediction. Nat. Methods 2, DOI:10.1038/NMETH780.
55. Overhoff M., Alken M., Far R. K., Lemaitre M., Lebleu B., Sczakiel G. and Robbins I. (2005) Local RNA target structure influences siRNA efficacy: a systematic global analysis. J. Mol. Biol. 348, 871-881.
56. Yiu S.M., Wong P.W., Lam T.W., Mui Y.C., Kung H. F., Lin M. and Cheung Y. T. (2005) Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics 21, 144-151.
57. Schubert S., Grunweller A., Erdmann V. A. and Kurreck J. (2005) Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J. Mol. Biol. 348, 883-893.
58. Pancoska P., Moravek Z. and Moll U. M. (2004) Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA. Nucleic Acids Res. 32, 1469-1479.
59. Heale B. S., Soifer H. S., Bowers C. and Rossi J. J. (2005) siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res. 33, e30.
60. Zuker M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.
61. Ren Y., Gong W., Xu Q., Zheng X., Lin D., Wang Y. and Li T. (2006) siRecords: an extensive database of mammalian siRNAs with efficacy ratings. Bioinformatics 22, 1027-1028.
62. Yamada T. and Morishita S. (2005) Accelerated off-target search algorithm for siRNA. Bioinformatics 21, 1316-1324.
63. Saxena S., Jonsson Z.O. and Dutta A. (2003) Small RNAs with imperfect match to endogenous mRNA repress translation: implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278, 44312-44319.
64. Lin X., Ruan X., Anderson M. G., McDowell J. A., Kroeger P. E., Fesik S.W. and Shen Y. (2005) siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res. 33, 4527-4535.
65. Qiu S., Adema C. M. and Lane T. (2005) A computational study of off-target effects of RNA interference. Nucleic Acids Res. 33, 1834-1847.
66. Naito Y., Yamada T., Matsumiya T., Ui-Tei K., Saigo K. and Morishita S. (2005) dsCheck: highly sensitive off-target search software for double-stranded RNA-mediated RNA interference. Nucleic Acids Res. 33, W589-W591.
67. Snove O., Jr. Nedland M., Fjeldstad S. H., Humberset H., Birkeland O. R., Grunfeld T. and Saetrom P. (2004) Designing effective siRNAs with off-target control. Biochem. Biophys. Res. Commun. 325, 769-773.
68. Elbashir S. M., Martinez J., Patkaniowska A., Lendeckel W. and Tuschl T. (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
69. Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W. and Lipman D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402.
70. Li W. and Ying X. (2006) MProbe 2.0: computer aided probe design for oligonucleotide microarrays. Appl. Bioinformatics 5, 181-186.
71. Snove O., Jr. and Holen T. (2004) Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun. 319, 256-263.
72. Jackson A. L., Bartz S. R., Schelter J., Kobayashi S. V., Burchard J., Mao M., Li B., Cavet G. and Linsley P. S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635-637.
73. Kane M.D., Jatkoe T. A., Stumpf C. R., Lu J., Thomas J.D. and Madore S. J. (2000) Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays.Nucleic Acids Res. 28, 4552-4557.
74. Birmingham A., Anderson E. M., Reynolds A., Ilsley-Tyree D., Leake D., Fedorov Y., Baskerville S., Maksimova E., Robinson K., Karpilow J. et al (2006) 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 3, 199-204.
75. Naito Y., Yamada T., Ui-Tei K., Morishita S. and Saigo K. (2004) siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 32, W124-W129.
76. Henschel A., Buchholz F. and Habermann B. (2004) DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res. 32, W113-W120.
77. Cui W., Ning J., Naik U. P. and Duncan M. K. (2004) OptiRNAi, an RNAi design tool. Comput. Methods Programs Biomed. 75, 67-73.
78. Dudek P. and Picard D. (2004) TROD: T7 RNAi Oligo Designer. Nucleic Acids Res. 32, W121-W123.
79. Arziman Z., Horn T. and Boutros M. (2005) E-RNAi: a web application to design optimized RNAi constructs. Nucleic Acids Res. 33, W582-W588.
80. Yuan B., Latek R., Hossbach M., Tuschl T. and Lewitter F. (2004) siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32, W130-W134.
81. Wang L. and Mu F. Y. (2004) A Web-based design center for vector-based siRNA and siRNA cassette. Bioinformatics 20, 1818-1820.
82. Levenkova N., Gu Q. and Rux J. J. (2004) Gene specific siRNA selector. Bioinformatics 20, 430-432.
83. Santoyo J., Vaquerizas J. M. and Dopazo J. (2005) Highly specific and accurate selection of siRNAs for high-throughput functional assays. Bioinformatics 21, 1376-1382.